Ghost Tree Capital »

Sagimet Biosciences Inc-a shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $770k 225k 3.42
2024-03-31 $1.2M 225k 5.42

More positions owned by Ghost Tree Capital

Alnylam Pharmaceuticals (ALNY)
Insmed Com Par $.01 (INSM)
Biohaven (BHVN)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Soleno Therapeutics (SLNO)
Axsome Therapeutics (AXSM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Vaxcyte (PCVX)
Crinetics Pharmaceuticals In (CRNX)
Roivant Sciences SHS (ROIV)
Perspective Therapeutics Com New (CATX)
Tg Therapeutics (TGTX)
Sarepta Therapeutics (SRPT)
Cg Oncology (CGON)
Corbus Pharmaceuticals Hldgs Com New (CRBP)

View all positions for Ghost Tree Capital

Top funds holding Sagimet Biosciences Inc-a

Point72 Asset Management
NEA Management Company
Blue Owl Capital Holdings
Baker Bros. Advisors
Alyeska Investment Group
Citadel Advisors
Vanguard Group
BlackRock
BlackRock
Rock Springs Capital Management
Hillhouse Capital Advisors
Siren
Partner Fund Management
Bank of America Corporation
Ikarian Capital

View all funds holding Sagimet Biosciences Inc-a